Therapeutic drug monitoring when using cefepime in continuous renal replacement therapy: Seizures associated with cefepime

Critical Care and Resuscitation

Volumn 14, Issue 4, 2012, Pages 312-315

  Smith, Nicholas L ^a   Freebairn, Ross C ^a   Park, Michael A J ^a   Wallis, Steven C ^b   Roberts, Jason A ^b   Lipman, Jeffrey ^b  

^a HAWKE S BAY HOSPITAL   (New Zealand)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CEFEPIME; CEPHALOSPORIN DERIVATIVE;

AGED; ARTICLE; CASE REPORT; CHEMICALLY INDUCED DISORDER; DRUG MONITORING; HEMOFILTRATION; HUMAN; MALE; METABOLIC CLEARANCE RATE; METHODOLOGY; PNEUMONIA; SEIZURE; SEPTIC SHOCK; TOXICITY AND INTOXICATION;

AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CEPHALOSPORINS; DRUG MONITORING; HEMOFILTRATION; HUMANS; MALE; METABOLIC CLEARANCE RATE; NEUROTOXICITY SYNDROMES; PNEUMONIA; SEIZURES; SHOCK, SEPTIC;

EID: 84873103652     PISSN: 14412772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Bilgrami I, Roberts JA, Wallis SC, et al. Meropenem dosing in critically ill patients with sepsis receiving high-volume continuous venovenous hemofiltration. Antimicrob Agents Chemother 2010; 54: 2974-8.
2. Patel K, Roberts JA, Lipman J. Population pharmacokinetics of fluconazole in critically ill patients receiving continuous venovenous hemodiafiltration: using Monte Carlo simulations to predict doses for specified pharmacodynamic targets. Antimicrob Agents Chemother 2011; 55: 5868-73.
3. Roberts JA, Field J, Visser A, et al. Using population pharmacokinetics to determine gentamicin dosing during extended daily diafiltration in critically ill patients with acute kidney injury. Antimicrob Agents Chemother 2010; 54: 3635-40.
4. Roberts DM, Roberts JA, Roberts MS, et al. Variability of antibiotic concentrations in critically ill patients receiving continuous renal replacement therapy: a multicentre pharmacokinetic study. Crit Care Med 2011; 40: 1523-8.
5. Mirski MA, Varelas PN. Seizures and status epilepticus in the critically ill. Crit Care Clin 2008; 24: 115-47, ix.
6. Sugimoto M, Uchida I, Mashimo T, et al. Evidence for the involvement of GABA(A) receptor blockade in convulsions induced by cephalosporins. Neuropharmacology 2003; 45: 304-14.
7. Chatellier D, Jourdain M, Mangalaboyi J, et al. Cefepime-induced neurotoxicity: an underestimated complication of antibiotherapy in patients with acute renal failure. Intensive Care Med 2002; 28: 214-7.
8. Chapuis TM, Giannoni E, Majcherczyk PA, et al. Prospective monitoring of cefepime in intensive care unit adult patients. Crit Care 2010; 14: R51.
9. Martinez-Rodríguez JE, Barriga FJ, Santamaria J, et al. Nonconvulsive status epilepticus associated with cephalosporins in patients with renal failure. Am J Med 2001; 111: 115-9.
10. Wong KM, Chan WK, Chan YH, Li CS. Cefepime-related neurotoxicity in a haemodialysis patient. Nephrol Dial Transplant 1999; 14: 2265-6.
11. Dixit S, Kurle P, Buyan-Dent L, Sheth RD. Status epilepticus associated with cefepime. Neurology 2000; 54: 2153-5.
12. Sonck J, Laureys G, Verbeelen D. The neurotoxicity and safety of treatment with cefepime in patients with renal failure. Nephrol Dial Transplant 2008; 23: 966-70.
13. Lipman J, Wallis SC, Rickard C. Low plasma cefepime levels in critically ill septic patients: pharmacokinetic modeling indicates improved troughs with revised dosing. Antimicrob Agents Chemother 1999; 43: 2559-61.
14. Choi G, Gomersall CD, Tian Q, et al. Principles of antibacterial dosing in continuous renal replacement therapy. Crit Care Med 2009; 37: 2268-82.
15. Roberts JA, Hope WW, Lipman J. Therapeutic drug monitoring of beta-lactams for critically ill patients: unwarranted or essential? Int J Antimicrob Agents 2010; 35: 419-20.
16. Roberts JA, Norris R, Paterson DL, Martin JH. Therapeutic drug monitoring of antimicrobials. Br J Clin Pharmacol 2012; 73: 27-36.